132 related articles for article (PubMed ID: 9327729)
1. Correlation between Bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors.
Lee GH
Am J Pathol; 1997 Oct; 151(4):957-61. PubMed ID: 9327729
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis initiated in infant B6C3F1 mice with diethylnitrosamine.
Lee GH; Ooasa T; Osanai M
Cancer Res; 1998 Apr; 58(8):1665-9. PubMed ID: 9563480
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma cell lines from diethylnitrosamine phenobarbital-treated rats. Characterization and sensitivity to endothall, a protein serine/threonine phosphatase-2A inhibitor.
Thièry JP; Blazsek I; Legras S; Marion S; Reynes M; Anjo A; Adam R; Misset JL
Hepatology; 1999 May; 29(5):1406-17. PubMed ID: 10216123
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
[TBL] [Abstract][Full Text] [Related]
5. The potential role of bcl-2 mRNA and protein exression in hepatocellular carcinomas.
Ravazoula P; Tsamandas AC; Kardamakis D; Gogos C; Karatza C; Thomopoulos K; Tepetes K; Kourelis T; Petsas T; Bonikos DS; Karavias D
Anticancer Res; 2002; 22(3):1799-805. PubMed ID: 12168872
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 positivity in B and C hepatitis and hepatocellular carcinomas.
Yildiz L; Baris S; Aydin O; Kefeli M; Kandemir B
Hepatogastroenterology; 2008; 55(88):2207-10. PubMed ID: 19260506
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
8. Bcl-xL overexpression in human hepatocellular carcinoma.
Watanabe J; Kushihata F; Honda K; Mominoki K; Matsuda S; Kobayashi N
Int J Oncol; 2002 Sep; 21(3):515-9. PubMed ID: 12168094
[TBL] [Abstract][Full Text] [Related]
9. Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens.
Christensen JG; Gonzales AJ; Cattley RC; Goldsworthy TL
Cell Growth Differ; 1998 Sep; 9(9):815-25. PubMed ID: 9751125
[TBL] [Abstract][Full Text] [Related]
10. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo.
Kang JS; Wanibuchi H; Morimura K; Gonzalez FJ; Fukushima S
Cancer Res; 2007 Dec; 67(23):11141-6. PubMed ID: 18056438
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
12. Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats.
Hara A; Sakata K; Yamada Y; Kuno T; Kitaori N; Oyama T; Hirose Y; Murakami A; Tanaka T; Mori H
Oncol Rep; 2005 Aug; 14(2):345-51. PubMed ID: 16012713
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
Feng D; Zheng H; Shen M; Cheng R; Yan Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):325-8. PubMed ID: 12080637
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of mutant frequencies of chemically induced tumors and normal tissues in lambda/cII transgenic mice.
Mirsalis JC; Shimon JA; Johnson A; Fairchild D; Kanazawa N; Nguyen T; de Boer J; Glickman B; Winegar RA
Environ Mol Mutagen; 2005; 45(1):17-35. PubMed ID: 15605353
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines.
Fantappiè O; Solazzo M; Lasagna N; Platini F; Tessitore L; Mazzanti R
Cancer Res; 2007 May; 67(10):4915-23. PubMed ID: 17510421
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of apoptosis by c-myc in transgenic hepatocytes and effects of growth factors and nongenotoxic carcinogens.
Christensen JG; Goldsworthy TL; Cattley RC
Mol Carcinog; 1999 Aug; 25(4):273-84. PubMed ID: 10449034
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions.
Kakehashi A; Kato A; Inoue M; Ishii N; Okazaki E; Wei M; Tachibana T; Wanibuchi H
Toxicol Appl Pharmacol; 2010 Jan; 242(1):47-55. PubMed ID: 19796649
[TBL] [Abstract][Full Text] [Related]
18. Quantitative electron microscopic analysis of changes in peroxisomes and endoplasmic reticulum induced in mice during hepatocarcinogenesis by diethylnitrosamine promoted by di(2-ethylhexyl)phthalate or phenobarbital.
Schuller HM; Ward JM
J Exp Pathol; 1984; 1(4):287-94. PubMed ID: 6599940
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells.
Chun E; Lee KY
Biochem Biophys Res Commun; 2004 Mar; 315(3):771-9. PubMed ID: 14975768
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
Loeppen S; Schneider D; Gaunitz F; Gebhardt R; Kurek R; Buchmann A; Schwarz M
Cancer Res; 2002 Oct; 62(20):5685-8. PubMed ID: 12384525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]